PSA (prostate-specific antigen) test

PSA test

Find reliable independent health and treatment information about the PSA (prostate-specific antigen) test written by Australian experts.

About prostate-specific antigen tests

The PSA (or prostate-specific antigen) test is a test for prostate cancer. Like any medical test, the PSA test is only recommended for some people, and should only be used if the potential benefits outweigh the risks.

We currently have no information specifically on prostate-specific antigen tests but we will be developing new resources as the need arises. In the meantime see the list of resource below, use the search box to find more, or review our information for health professionals – so you can discuss this with your health carer.

For health professionals  

Elevated prostate-specific antigen levels are not specific to prostate cancer and elevated levels can cause patients to worry unnecessarily. Men who enquire about such tests should make an informed decision after being adequately counselled on risks (e.g. unnecessary biopsy) as well as the benefits. Although testing can detect prostate cancer early, before it causes symptoms, the prostate-specific antigen test is currently not recommended in Australia for population screening purposes.1-3

Clinical information

Quality use of medical tests means choosing the right test for the patient and using it at the right time. We have compiled some of the latest evidence and guidelines on prostate specific antigen tests to help you discuss the relevance of this with your patients.

References
  1. Australian Health Ministers' Advisory Council. Prostate cancer screening in Australia: position statement. 2010. [Online] (accessed 22 November 2012).
  2. Guidelines for preventive activities in general practice (The Red Book) 8th Edition. Melbourne: Royal Australian College of General Practitioners, 2012. [Online] (accessed 8 January 2013).
  3. Cancer Council Australia. National Cancer Prevention Policy: Prostate Cancer. [Online] (accessed 30 November 2012).

Related information - PSA test

Audience:
       

For health professionals (Health professional publication)
09 Sep 2013 Finasteride, used to treat benign prostatic hyperplasia and baldness, may reduce the harm of PSA screening but may increase the incidence of aggressive high-grade tumours.
(Medical test)
28 Jun 2013 Find out about screening tests for prostate cancer, when they are used, and their risks and benefits.
For health professionals (Medical test)
23 May 2013 Prostate cancer is a common cancer in men, but routine testing for prostate cancer is not recommended for healthy asymptomatic men. Read the evidence
For health professionals (Medical test)
23 May 2013 Prostate cancer is a common cancer in men, but routine testing for prostate cancer is not recommended for healthy asymptomatic men. Read the evidence
For health professionals (Medical test)
23 May 2013 Prostate cancer is a common cancer in men, but routine testing for prostate cancer is not recommended for healthy asymptomatic men. Read the evidence